Annals of the New York Academy of Sciences
-
Ann. N. Y. Acad. Sci. · Nov 1994
ReviewAntioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
The current research has demonstrated that MPP+ can induce lipid peroxidation in the nigrostriatal system of rat in vivo. Antioxidant agent U-78517F and. OH scavenger DMSO may protect against MPP+ toxicity through the inhibition of. ⋯ Finally, based on the present data, a possible neuroprotective therapeutic window of deprenyl in the treatment of early Parkinson's disease has been proposed. It is suggested that deprenyl should be introduced as early as possible in de novo Parkinsonian patients to achieve its full neuroprotective effect on nigral degeneration. Moreover, a combination of early detection of individuals at risk of developing Parkinson's disease and early intervention of deprenyl and/or other centrally active antioxidants to these patients may provide a new preventive therapeutic strategy in the future, in addition to the current conventional levodopa treatment of Parkinson's disease.